You are here
Aspen Ideas Scholar: Monique Carter
This year, Pfizer leaders nominated three scholars to represent our company among a diverse group of 300 global leaders, selected for their work and accomplishments—and for their ability to transform ideas into action. Meet our scholars and learn about their experience at the 2017 Aspen Ideas Festival.
Meet Monique Carter, MS, RAC is a Regulatory Scientist and Global Regulatory Lead at Pfizer in Worldwide Safety and Regulatory. At Pfizer, Monique leads innovative and adaptive drug development strategies ranging from the early investigational space through post marketing approval.
What are you most looking forward to learning at the Aspen Ideas Festival?
I’m most excited about The Brain Track –looking forward to gaining insight into the latest innovative neuro-technologies being developed to support treating serious, life-threatening neurodegenerative diseases as early and as fast as possible.
What panels are you looking forward to attending at the Aspen Ideas Festival?
I will be front and center at the many Aging Brain presentations, including a talk to begiven by Alzheimer’s disease expert Sam Gandy.I look forward to discussing with experts and fellow scholars the impact of aging as it relates to neurotoxic peptide accumulation in the brain, imaging, and appropriate endpoints to assess treatment outcomes as early as thepre-symptomatic stages of disease.
If you were speaking on a panel at Aspen Ideas Festival, what would you be speaking about?
If given the opportunity to speak I would focus on the importance of utilizing expedited and adaptive regulatory pathways developed by Health Authorities to support accelerating access to innovative medicines for devastating diseases such as Alzheimer’s and Parkinson’s.I would love the opportunity to lead a multi-stakeholder discussion including patients, senior regulators, and payers from across the globe to allow for sharing of different perspectives on the benefits and risks associated with shifting specific market access requirements to the post-approval settingfor promising medicines.
Check back in a few days to hear about our scholars’ experiences.
- What were your favorite panels or sessions that you attended?
- What did you learn from these panels?
- What is one thing you learned at Aspen that you’d be applying to your work life?
Monique Carter, MS, RAC is a Regulatory Scientist and Global Regulatory Lead at Pfizer in Worldwide Safety and Regulatory – Global Innovative Pharma Business in the Neuroscience & Pain therapeutic area. At Pfizer, Monique leads innovative and adaptive drug development strategies ranging from the early investigational space through post marketing approval. Prior to joining Pfizer, Monique worked as a cross-functional regulatory and clinical development strategy team leader across the drug development continuum spanning a host of therapeutic areas in global biotechnology investment firm and management consulting settings. Monique holds a BA in Biochemistry and Physics from Baylor University and a MS in Biotechnology with a concentration in Regulatory Science from Johns Hopkins University. She is based in Collegeville, PA.